Evidence map›Paper›PMID 39229784›Full record

ReviewFuture microbiology2024

Spotlight on the epidemiology and antimicrobial susceptibility profiles of

Rayane Rafei, Marwan Osman, Issmat I Kassem, Fouad Dabboussi, François-Xavier Weill, Monzer Hamze

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Future microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Occurrence and Distribution ofFoods (Basel, Switzerland) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Rayane RafeiLaboratoire Microbiologie, Santé et Environnement (LMSE), Doctoral School of Sciences & Technology, Faculty of Public Health, Lebanese University, Tripoli, 1300, Lebanon.ORCID 0000-0001-9633-1290
Marwan OsmanDepartment of Neurosurgery, Yale University School of Medicine, New Haven, CT 06510, USA.ORCID 0000-0002-6235-2760
Issmat I KassemCenter for Food Safety, Department of Food Science & Technology, University of Georgia, 1109 Experiment Street, Griffin, GA 30223-1797, USA.ORCID 0000-0002-2978-9573
Fouad DabboussiLaboratoire Microbiologie, Santé et Environnement (LMSE), Doctoral School of Sciences & Technology, Faculty of Public Health, Lebanese University, Tripoli, 1300, Lebanon.ORCID 0000-0002-9211-2370
François-Xavier WeillInstitut Pasteur, Université Paris Cité, Unité des Bactéries pathogènes entériques, Centre National de Référence des vibrions et du choléra, Paris, F-75015, France.ORCID 0000-0001-9941-5799
Monzer HamzeLaboratoire Microbiologie, Santé et Environnement (LMSE), Doctoral School of Sciences & Technology, Faculty of Public Health, Lebanese University, Tripoli, 1300, Lebanon.ORCID 0000-0001-7466-5118

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent cholera outbreaks in many countries in the Middle East and North Africa (MENA) region have raised public health concerns and focused attention on the genus

Indexed as

Anti-Bacterial AgentsVibrioVibrio InfectionsAfrica, NorthernCholeraDisease OutbreaksDrug Resistance, BacterialHumansMicrobial Sensitivity TestsMiddle EastSeafoodAnti-Bacterial Agentsantibiotic resistancecholeraMENAoutbreaksprevalencepublic healthVibriovibriosis

Identifiers

PMID39229784
PMCPMC11486259

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.